MetaADEDB 2.0 @ LMMD
Naltrexone
(RHBRMCOKKKZVRY-ITLPAZOVSA-N)
Structure
SMILES
O=C1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O.Cl
Molecular Formula:
C20H24ClNO4
Molecular Weight:
377.862
Log P:
2.2653
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
3
TPSA:
70
CAS Number(s):
16676-29-2
Synonym(s)
1.
Naltrexone
2.
Antaxone
3.
Celupan
4.
EN-1639A
5.
Nalorex
6.
Naltrexone Hydrochloride
7.
Nemexin
8.
ReVia
9.
Trexan
10.
EN 1639A
11.
EN1639A
External Link(s)
MeSHD009271
PubChem Compound11760614
5485201
5388998
ChEBI134687
CHEMBLCHEMBL1201149
KEGGdr:D02095
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Accidental overdoseFAERS: 7US FAERS
2VomitingFAERS: 5US FAERS
3AgitationFAERS: 3US FAERS
4AnxietyFAERS: 3US FAERS
5DizzinessFAERS: 3US FAERS
6Drug ineffectiveFAERS: 3US FAERS
7NauseaFAERS: 3US FAERS
8Abdominal PainFAERS: 2US FAERS
9ArthralgiaFAERS: 2US FAERS
10AstheniaFAERS: 2US FAERS
11Back PainFAERS: 2US FAERS
12CholecystitisFAERS: 2US FAERS
13Drug screen false positiveFAERS: 2US FAERS
14Drug withdrawal syndromeFAERS: 2US FAERS
15Injection Site ReactionFAERS: 2US FAERS
16Medication ErrorFAERS: 2US FAERS
17MydriasisFAERS: 2US FAERS
18Neck PainFAERS: 2US FAERS
19PancytopeniaFAERS: 2US FAERS
20PiloerectionFAERS: 2US FAERS
21PresyncopeFAERS: 2US FAERS
22SepsisFAERS: 2US FAERS
23SomnolenceFAERS: 2US FAERS
24TachycardiaFAERS: 2US FAERS
25TremorFAERS: 2US FAERS
26UrticariaFAERS: 2US FAERS
27Abdominal discomfortFAERS: 1US FAERS
28Acute psychosisFAERS: 1US FAERS
29Alanine Aminotransferase IncreasedFAERS: 1US FAERS
30Apallic syndromeFAERS: 1US FAERS
31AphagiaFAERS: 1US FAERS
32Cardiac TamponadeFAERS: 1US FAERS
33Chest PainFAERS: 1US FAERS
34DehydrationFAERS: 1US FAERS
35DependenceFAERS: 1US FAERS
36DisorientationFAERS: 1US FAERS
37Drug abuserFAERS: 1US FAERS
38Drug exposure during pregnancyFAERS: 1US FAERS
39Drug screen positiveFAERS: 1US FAERS
40Expired product administeredFAERS: 1US FAERS
41False positive laboratory resultFAERS: 1US FAERS
42FatigueFAERS: 1US FAERS
43Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
44Gastric infectionFAERS: 1US FAERS
45Gastrointestinal wall thickeningFAERS: 1US FAERS
46Hallucinations, mixedFAERS: 1US FAERS
47Ileal StenosisFAERS: 1US FAERS
48Implant site painFAERS: 1US FAERS
49Inappropriate schedule of product administrationFAERS: 1US FAERS
50IncoherentFAERS: 1US FAERS
51Injection site noduleFAERS: 1US FAERS
52Injection site painFAERS: 1US FAERS
53Injury asphyxiationFAERS: 1US FAERS
54LeukopeniaFAERS: 1US FAERS
55Lip swellingFAERS: 1US FAERS
56Musculoskeletal PainFAERS: 1US FAERS
57Musculoskeletal stiffnessFAERS: 1US FAERS
58NervousnessFAERS: 1US FAERS
59Opiates positiveFAERS: 1US FAERS
60OverdoseFAERS: 1US FAERS
61PainFAERS: 1US FAERS
62Pericardial effusionFAERS: 1US FAERS
63PleuropericarditisFAERS: 1US FAERS
64PosturingFAERS: 1US FAERS
65PregnancyFAERS: 1US FAERS
66Product preparation errorFAERS: 1US FAERS
67Product quality issueFAERS: 1US FAERS
68Product substitution issueFAERS: 1US FAERS
69Product use issueFAERS: 1US FAERS
70Protein total increasedFAERS: 1US FAERS
71RestlessnessFAERS: 1US FAERS
72RetchingFAERS: 1US FAERS
73ScabFAERS: 1US FAERS
74Self MutilationFAERS: 1US FAERS
75Sinus TachycardiaFAERS: 1US FAERS
76Skeletal injuryFAERS: 1US FAERS
77Skin necrosisFAERS: 1US FAERS
78StressFAERS: 1US FAERS
79Suicide attemptFAERS: 1US FAERS
80Temperature intoleranceFAERS: 1US FAERS
81Therapy non-responderFAERS: 1US FAERS
82ThrombosisFAERS: 1US FAERS
83Unresponsive to stimuliFAERS: 1US FAERS
84Weight decreasedFAERS: 1US FAERS
85Depressed moodCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.